CN1116098A - Medicinal composition for tympanitis - Google Patents
Medicinal composition for tympanitis Download PDFInfo
- Publication number
- CN1116098A CN1116098A CN94112423A CN94112423A CN1116098A CN 1116098 A CN1116098 A CN 1116098A CN 94112423 A CN94112423 A CN 94112423A CN 94112423 A CN94112423 A CN 94112423A CN 1116098 A CN1116098 A CN 1116098A
- Authority
- CN
- China
- Prior art keywords
- otitis media
- pharmaceutical composition
- powder
- grams
- tympanitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a kind of medicinal composite for curing otitis media. Said mechicine consists of (by weight proportion) 1-2 of powder os nake slough, 20-25 of alum and 15-20 of borneol. Said medicine is powder.
Description
The present invention relates to a kind of pharmaceutical composition for the treatment of otitis media.
Otitis media is commonly called as the eardrum inflammation, is a kind of commonly encountered diseases, and no matter frequently-occurring disease is neonate or teenager, or middle age and old people, and the sickness rate of otitis media is all very high.General neonate all makes tear or milk flow into auditory meatus easily, thereby causes otitis media because of cryying or the milk that overflows.And teenager or old people then because swimming, bathing etc., or because of disease such as catching a cold, all cause otitis media easily, and gently then auditory meatus is suppurated incessantly for a long time, and be heavy then cause deafness.Treat otitis media at present clinically, generally adopt external auditory meatus to clean, and large dose oral administration or injection antibiotics, yet, in fact, a large amount of medicines then excrete by metabolism, thereby, can't keep the drug level of inflammation part effectively, cause the course of disease to prolong, or miss the Best Times of treatment.
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of otitis media, this pharmaceutical composition can directly be used in diseased region, thus disease controlling development effectively, and reach the healing purpose rapidly.
The objective of the invention is to adopt following technical scheme to be achieved: the weight ratio that this pharmaceutical composition is formed is:
Periostracum Serpentis powder: Alumen: Borneolum Syntheticum=1-2: 20-25: 15-20.
Above-mentioned compound composition needs certain fineness, and promptly each active ingredient all needs more than porphyrize to 60 order in the prescription, fully absorbs thereby help affected part.Certainly, fineness is lower than 60 purpose powder and also can uses.
Because the present invention has adopted technique scheme, feels a puzzled difficult problem for a long time deeply thereby solved medical circle with succinct prescription, for extensive patients has been brought Gospel always.
Below in conjunction with embodiment in detail the present invention is described in detail:
Embodiment 1:
Get Periostracum Serpentis 10 grams, Alumen 200 grams, Borneolum Syntheticum 150 grams, fully more than porphyrize to 60 order, this formula constituent can be used for children's or teenager otitis media patient, generally adds medicine to and can cure in 3-5 days.
Embodiment 2:
Get Periostracum Serpentis 20 grams, Alumen 250 grams, Borneolum Syntheticum 200 grams, fully more than porphyrize to 60 order.This formula constituent can be used for person in middle and old age's otitis media patient.General chronic otitis media can be cured, and to the vague generalization purulent otitis media, can be cured in 10-15 days in 5-10 days.
Embodiment 3:
Get Periostracum Serpentis 15 grams, Alumen 200 grams, Borneolum Syntheticum 150 grams, fully more than porphyrize to 60 order.This formula constituent is all applicable to vague generalization purulent otitis media and chronic otitis media, can cure in general 5-12 days.
Embodiment 4:
Other is with embodiment 3, but fineness of powder is 20 orders or more than 20 orders, still has obvious therapeutic effect.
Claims (2)
1. pharmaceutical composition for the treatment of otitis media, it is characterized in that: this pharmaceutical composition comprises Periostracum Serpentis powder, Alumen and Borneolum Syntheticum, it is formed weight ratio and is: Periostracum Serpentis powder: Alumen: Borneolum Syntheticum=1-2: 20-25: 15-20, described pharmaceutical composition is a powder.
2. pharmaceutical composition according to claim 1 is characterized in that: described pharmaceutical composition fineness is greater than 60 orders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94112423A CN1116098A (en) | 1994-08-04 | 1994-08-04 | Medicinal composition for tympanitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94112423A CN1116098A (en) | 1994-08-04 | 1994-08-04 | Medicinal composition for tympanitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1116098A true CN1116098A (en) | 1996-02-07 |
Family
ID=5036106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94112423A Pending CN1116098A (en) | 1994-08-04 | 1994-08-04 | Medicinal composition for tympanitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1116098A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060381C (en) * | 1997-03-26 | 2001-01-10 | 葛太兴 | External-use Chinese medicine for treating acute and chronic festering otitis media |
| CN103977052A (en) * | 2014-05-23 | 2014-08-13 | 李绍礼 | Pharmaceutical composition for treating tinnitus and tympanitis |
-
1994
- 1994-08-04 CN CN94112423A patent/CN1116098A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1060381C (en) * | 1997-03-26 | 2001-01-10 | 葛太兴 | External-use Chinese medicine for treating acute and chronic festering otitis media |
| CN103977052A (en) * | 2014-05-23 | 2014-08-13 | 李绍礼 | Pharmaceutical composition for treating tinnitus and tympanitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5589480A (en) | Topical application of opioid analgesic drugs such as morphine | |
| RU2005129267A (en) | DRUGS FOR TRANSMISSION AND TRANSMISIONAL DELIVERY | |
| JP2002500180A5 (en) | ||
| WO2004017913A3 (en) | Arginine silicate inositol complex and use thereof | |
| CN103301254B (en) | Antibacterial liquid used for nasopharyal meatus and preparation method thereof | |
| US4469702A (en) | Analgesic composition and use thereof to ameliorate deep and intractable pain | |
| CN1116098A (en) | Medicinal composition for tympanitis | |
| CZ147894A3 (en) | Pain inhibiting pharmacological preparation and process for preparing thereof | |
| CN1160086C (en) | Yatong Yicijing medicine for curing toothache | |
| CN1073360C (en) | Trollflower health-care tea | |
| CN112933122B (en) | Traditional Chinese medicine external medicine for treating recurrent oral ulcer | |
| CN1052906C (en) | External application medicine for treating toothache due to saprodontia | |
| WO1998029104A3 (en) | Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis | |
| MR | Practical Applicability of Nasya Karma (Ayurveda Therapy) in Sinusitis | |
| CN106214906B (en) | Medicinal composition for treating bromhidrosis and preparation method thereof | |
| Gans | Aureomycin in treatment of otitic and ophthalmic herpes zoster | |
| EP1249242B1 (en) | Natural-Phytotherapic composition based on hydroglyceric extracts for aerosol therapy | |
| CN1092655A (en) | A kind of medicine for the treatment of hemorrhoid | |
| Moroney | Product focus: Otrivin Plus | |
| CN1084627C (en) | Traditional Chinese medicinal plaster for treating psoriasis | |
| CN117064963A (en) | Traditional Chinese medicine formula preparation for treating rhinitis and processing method thereof | |
| CN2427232Y (en) | Navel treatment plaster for treating cold | |
| CN1060343C (en) | Anti-infection and anti-inflammation drugs | |
| JPS6229529A (en) | Manufacture of medicine for disease | |
| CN103623007A (en) | Externally-applied ointment for treating ringworm of scalp and preparation and application methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |